ATE507309T1 - Verfahren zur erkennung eines oralen plattenepithelkarzinoms und mittel zu dessen unterdrückung - Google Patents

Verfahren zur erkennung eines oralen plattenepithelkarzinoms und mittel zu dessen unterdrückung

Info

Publication number
ATE507309T1
ATE507309T1 AT09151217T AT09151217T ATE507309T1 AT E507309 T1 ATE507309 T1 AT E507309T1 AT 09151217 T AT09151217 T AT 09151217T AT 09151217 T AT09151217 T AT 09151217T AT E507309 T1 ATE507309 T1 AT E507309T1
Authority
AT
Austria
Prior art keywords
cell carcinoma
oral squamous
suppressing
carcinoma
detecting
Prior art date
Application number
AT09151217T
Other languages
English (en)
Inventor
Johji Inazawa
Ken-Ichi Kozaki
Issei Imoto
Original Assignee
Fujifilm Corp
Nat Univ Corp Tokyo Med & Dent
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujifilm Corp, Nat Univ Corp Tokyo Med & Dent filed Critical Fujifilm Corp
Application granted granted Critical
Publication of ATE507309T1 publication Critical patent/ATE507309T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/154—Methylation markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333—Saccharide [e.g., DNA, etc.]
AT09151217T 2008-01-23 2009-01-23 Verfahren zur erkennung eines oralen plattenepithelkarzinoms und mittel zu dessen unterdrückung ATE507309T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2008012256A JP5116026B2 (ja) 2008-01-23 2008-01-23 癌の検出方法および癌抑制剤

Publications (1)

Publication Number Publication Date
ATE507309T1 true ATE507309T1 (de) 2011-05-15

Family

ID=40748687

Family Applications (1)

Application Number Title Priority Date Filing Date
AT09151217T ATE507309T1 (de) 2008-01-23 2009-01-23 Verfahren zur erkennung eines oralen plattenepithelkarzinoms und mittel zu dessen unterdrückung

Country Status (5)

Country Link
US (2) US20090202624A1 (de)
EP (1) EP2088208B1 (de)
JP (1) JP5116026B2 (de)
AT (1) ATE507309T1 (de)
DE (1) DE602009001116D1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5567555B2 (ja) * 2009-04-16 2014-08-06 学校法人慶應義塾 頭頸部腫瘍増殖抑制剤
EP2283846A1 (de) 2009-08-12 2011-02-16 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. miRNA-Verbindungen zur Behandlung von Prostatakarzinomen
JP5812491B2 (ja) * 2009-10-01 2015-11-11 国立研究開発法人国立がん研究センター 腫瘍治療剤
WO2011067346A1 (en) * 2009-12-04 2011-06-09 Institut National De La Sante Et De La Recherche Medicale (Inserm) Method for determining the efficiency of a cancer treatment
ES2573669T3 (es) 2010-07-08 2016-06-09 Takeda Pharmaceutical Company Limited Agente profiláctico o terapéutico para la diabetes
KR101532210B1 (ko) * 2011-05-06 2015-06-29 중산 호스피탈 푸단 유니버시티 플라즈마 마크로알엔에이로 구성된 간암 진단 마커 및 간암 진단의 새로운 방법
CN103857796A (zh) 2011-09-16 2014-06-11 Lsip基金运营联合公司 膀胱癌细胞的检测方法、用于膀胱癌细胞的检测方法的引物及膀胱癌标记物
WO2013071502A1 (en) 2011-11-17 2013-05-23 Genedia Biotech Co Ltd Mir-193a-3p and associated genes predict tumorigenesis and chemotherapy outcomes
EP3369818B1 (de) * 2011-12-22 2021-06-09 InteRNA Technologies B.V. Mirna zur behandlung von kopf-hals-karzinom
WO2014126233A1 (ja) 2013-02-15 2014-08-21 国立大学法人東京医科歯科大学 マイクロｒｎａの測定方法、並びに、がん治療剤及びこれを含有するがん治療のための医薬組成物
WO2017079571A1 (en) * 2015-11-05 2017-05-11 Arphion Diagnostics Process for the indentication of patients at risk for oscc
AU2018364916A1 (en) * 2017-11-09 2020-06-18 Purmx Therapeutics, Inc. Therapeutic pharmaceutical composition for cancer including miRNA
US20210071259A1 (en) * 2017-12-13 2021-03-11 Hiroshima University Method for assisting detection of head and neck cancer
US20220296629A1 (en) * 2019-06-03 2022-09-22 Carmel Haifa University Economic Corporation Ltd. Human head and neck cancer treatment
TW202122572A (zh) 2019-08-09 2021-06-16 日商宇部興產股份有限公司 胞外體的產生方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2554818A1 (en) 2004-02-09 2005-08-25 Thomas Jefferson University Diagnosis and treatment of cancers with microrna located in or near cancer-associated chromosomal features
CA2850323A1 (en) 2004-11-12 2006-12-28 Asuragen, Inc. Methods and compositions involving mirna and mirna inhibitor molecules
EP2487253B1 (de) * 2006-01-05 2015-06-24 The Ohio State University Research Foundation Verfahren und Zusammensetzungen auf Mikro-RNA-Basis zur Diagnose und Behandlung von festen Krebsen
WO2007081720A2 (en) * 2006-01-05 2007-07-19 The Ohio State University Research Foundation Microrna-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer
WO2007126150A1 (ja) * 2006-04-27 2007-11-08 National University Corporation Nagoya University 癌の新規治療用組成物
ES2447850T3 (es) * 2006-07-13 2014-03-13 The Ohio State University Research Foundation Métodos y composiciones basados en micro-ARN para el pronóstico y tratamiento de enfermedades relacionadas con el colon

Also Published As

Publication number Publication date
US8183223B2 (en) 2012-05-22
US20090202624A1 (en) 2009-08-13
US20110076768A1 (en) 2011-03-31
EP2088208A1 (de) 2009-08-12
EP2088208B1 (de) 2011-04-27
JP2009171876A (ja) 2009-08-06
DE602009001116D1 (de) 2011-06-09
JP5116026B2 (ja) 2013-01-09

Similar Documents

Publication Publication Date Title
ATE507309T1 (de) Verfahren zur erkennung eines oralen plattenepithelkarzinoms und mittel zu dessen unterdrückung
ATE522627T1 (de) Verfahren zur herstellung von nukleinsäuresonden
DE602007002090D1 (de) Verfahren zur Erkennung von anaplastischem Schilddrüsenkrebs, und Verfahren zur seiner Unterdrückung
EP3971299A3 (de) Kolorektalkrebsdetektionskit oder -vorrichtung und detektionsverfahren
WO2010129019A3 (en) Real-time sequencing methods and systems
DK3581662T3 (da) Sammensætninger og fremgangsmåder til detektering og identificering af nukleinsyresekvenser i biologiske prøver
WO2011055916A3 (ko) 장암 진단을 위한 장암 특이적 메틸화 마커 유전자의 메틸화 검출방법
WO2011141908A3 (en) Fluids testing apparatus and methods of use
BRPI0919882A8 (pt) Métodos para avaliar padrões de rna
WO2015058008A3 (en) Enhanced nucleic acid identification and detection
DE602006003880D1 (de) Verfahren zur herstellung von multimetallkatalysatoren, die bei kohlenwasserstoffumwandlungsreaktionen verwendet werden können
WO2008054556A3 (en) Methods and compositions for detection of a target nucleic acid sequence
EP2314680A4 (de) Verfahren zur amplifikation einer zielnukleinsäuresequenz, verfahren zum mutationsnachweis mit dem verfahren und reagentien zur verwendung in den verfahren
WO2010107816A3 (en) Nucleic acid binding dyes and uses therefor
DE602008006254D1 (de) Doppel-oligonukleotid-nukleinsäurenachweisverfahren
WO2013106844A3 (en) Methods and compositions for the treatment and diaginosis of pancreatic cancer
MY160850A (en) Polymer-bonded perylene dyes and compositions containing same
ATE533838T1 (de) Verfahren zur verbesserten einführung von dna in bakterienzellen
HK1133295A1 (en) Use of protein s100a12 as a marker for colorectal cancer s100a12
WO2009132126A3 (en) Method for predicting risk of metastasis
AT10182U3 (de) Verfahren zur überwachung von leistungsprüfständen, sowie leistungsprüfstand
WO2012107841A3 (en) Micro -rna biomarkers for identifying risk of and/or for diagnosing lung tumour and pharmaceutical compositions thereof
MX363880B (es) Sondas, cebadores cooperativos y aplicaciones de ellos.
WO2013102108A3 (en) Nucleic acid hybridization probes
EP2504348A4 (de) Verfahren, reagenzien und kits für den nachweis von nukleinsäuremolekülen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties